Literature DB >> 28815752

Rapidly progressive intravascular primary effusion lymphoma in an HIV-positive renal transplant recipient.

Owen Cain1, Adrian Yoong2, Graham Lipkin3, Mia Huengsberg4, Jim Murray5, Zbigniew Rudzki6, Bindu Vydianath1.   

Abstract

We describe the clinical and post-mortem findings of a case of rapidly progressive, ultimately fatal primary effusion lymphoma (PEL) arising in an HIV-positive man 2 years after renal transplantation. Disseminated multi-organ involvement associated with a peculiar intravascular pattern of growth, as seen in this case, has only been reported once previously. This is also, to our knowledge, the first detailed description of a lymphoma arising post-transplant in an HIV-positive patient.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990EBVzzm321990; zzm321990HIVzzm321990; immunodeficiency; lymphoma; transplantation

Mesh:

Year:  2017        PMID: 28815752     DOI: 10.1111/his.13347

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  2 in total

1.  Primary effusion lymphoma occurring in the setting of transplanted patients: a systematic review of a rare, life-threatening post-transplantation occurrence.

Authors:  Magda Zanelli; Francesca Sanguedolce; Maurizio Zizzo; Andrea Palicelli; Maria Chiara Bassi; Giacomo Santandrea; Giovanni Martino; Alessandra Soriano; Cecilia Caprera; Matteo Corsi; Stefano Ricci; Linda Ricci; Stefano Ascani
Journal:  BMC Cancer       Date:  2021-04-27       Impact factor: 4.430

2.  EBV-positive large B-cell lymphoma with an unusual intravascular presentation and associated haemophagocytic syndrome in an HIV-positive patient: report of a case expanding the spectrum of EBV-positive immunodeficiency-associated lymphoproliferative disorders.

Authors:  Luis Veloza; Chun-Yi Tsai; Bettina Bisig; Olivier Pantet; Lorenzo Alberio; Christine Sempoux; Matthias Cavassini; Laurence de Leval
Journal:  Virchows Arch       Date:  2021-06-19       Impact factor: 4.535

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.